Global Biologics Testing Market Revenue Expected To Reach $15.07 Billion By 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Size Of The Biologics Testing Market Progress Through 2030?

The biologics testing market has experienced significant expansion recently. Projections indicate a rise from $6.83 billion in 2025 to $7.99 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.0%. Historically, this growth was driven by factors such as increased manufacturing volumes for biologics, an uptick in vaccine development initiatives, stricter regulatory demands for product safety, the broader acceptance of monoclonal antibody treatments, and the proliferation of contract testing laboratories.

The biologics testing market is projected to expand quickly over the coming years, anticipated to reach a valuation of $15.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.2%. This growth can be attributed to several factors including the escalating demand for rapid release testing, a surge in the adoption of automated quality control systems, the broadening requirements for cell and gene therapy testing, an intensifying focus on data integrity, and increased investments in digital laboratory infrastructure. Furthermore, major developments within this period are expected to include the greater adoption of advanced analytical testing platforms, an increased call for comprehensive biologics quality testing, the expanding application of high-sensitivity assays, the widening scope of outsourced testing services, and a heightened emphasis on regulatory compliance testing.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp

What Are The Main Drivers Accelerating The Growth Of The Biologics Testing Market?

The expansion of the pharmaceutical and biotechnology sectors is projected to drive the biologics testing market forward. The pharmaceutical industry concentrates on creating and producing medicines for diverse ailments and health conditions. Meanwhile, the biotechnology industry applies technology to biological processes and healthcare. Biologics testing encompasses examinations to detect and measure impurities, evaluate stability, and gauge the immune reaction to a medication. The expansion of these industries has also spurred progress in biologics testing technology, including the creation of novel analytical instruments and methods. This has enabled more precise and effective testing, thereby shortening the development timeline and costs associated with introducing new biologics. For example, in July 2024, as per Eurostat, a Belgium-based governing body, pharmaceutical production in the EU escalated to €44 billion ($46.7 billion) in 2023, indicating substantial growth within the sector. Consequently, the burgeoning pharmaceutical and biotechnology industries are propelling the biologics testing market’s expansion.

Which Segment Groups Define The Biologics Testing Market Landscape?

The biologics testing market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Other Products

2) By Test Type: Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And DNA Detection Tests, Virus Safety Test, Other Test Types

3) By Application: Vaccine Development And Manufacturing, Monoclonal Antibodies Development And Manufacturing, Cellular And Gene Therapy Products Development And Manufacturing, Blood And Blood Products Development And Manufacturing, Other Applications

Subsegments:

1) By Reagents And Kits: ELISA Kits, PCR Kits, Cell Culture Reagents

2) By Instruments: Spectrophotometers, Chromatography Systems, Microplate Readers

3) By Other Products: Software, Consumables, Reference Standards

What Trends Are Affecting The Growth Of The Biologics Testing Market?

Major companies operating in the biological testing market are actively pursuing innovative technologies, such as protein engineering techniques, to enhance their market profitability. Protein engineering is defined as the process of designing and modifying proteins to create new or improved variants possessing desired characteristics. A notable illustration is the Queensland University of Technology, an Australia-based university, which in July 2023, unveiled a novel protein-engineering technique enabling the quick and precise creation of new diagnostic tests. This advancement offers a new approach for improving and broadening laboratory testing capabilities, promising substantial positive effects on both public health and economic sectors.

Which Industry Players Are Present In The Biologics Testing Market?

Major companies operating in the biologics testing market are Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, QIAGEN N.V., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG

Access The Complete Biologics Testing Market Report:

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

Which Region Is The Primary Market For The Biologics Testing Market?

North America was the largest region in the biologics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Biologics Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=10276&type=smp

Browse Through More Reports Similar to the Global Biologics Testing Market 2026, By The Business Research Company

Biologics Contract Development Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

Veterinary Biologics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

Biologics Cdmo Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-cdmo-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795